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Abstract 
Background: 
A range of non-communicable diseases (NCDs) has been found to follow a social pattern 
whereby socioeconomic status predicts either a higher or lower risk of disease. 
Comprehensive evidence on the socioeconomic distribution of NCDs across Europe however, 
has been limited. 
Methods: 
Using cross-sectional 2014 European Social Survey data from 20 countries, this paper 
examines socioeconomic inequalities in 14 self-reported NCDs separately for women and 
men: heart/circulatory problems, high blood pressure, back pain, arm/hand pain, foot/leg pain, 
allergies, breathing problems, stomach/digestion problems, skin conditions, diabetes, severe 
headaches, cancer, obesity and depression. Using education to measure socioeconomic status, 
age-controlled adjusted risk ratios were calculated and separately compared a lower and 
medium education group with a high education group.  
Results: 
At the pooled European level, a social gradient in health was observed for 10 NCDs: 
depression, diabetes, obesity, heart/circulation problems, hand/arm pain, high blood pressure, 
breathing problems, severe headaches, foot/leg pain and cancer. An inverse social gradient 
was observed for allergies. Social gradients were observed among both genders, but a greater 
number of inequalities were observed among women. Country-specific analyses show that 
inequalities in NCDs are present everywhere across Europe and that inequalities exist to 
different extents for each of the conditions. 
Conclusion: 
This study provides the most up-to-date overview of socioeconomic inequalities for a large 
number of NCDs across 20 European countries for both women and men. Future 
investigations should further consider the diseases, and their associated determinants, for 
which socioeconomic differences are the greatest.   
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Introduction 
The increasing prevalence of non-communicable diseases (NCDs) is now recognized 
as a global crisis [1]. In Europe, NCDs are the leading cause of mortality and morbidity.[2] 
These diseases not only cause unnecessary suffering and premature death but also have 
negative societal and economic impacts.[3] 
The World Health Organization defines NCDs as “diseases of long duration and 
generally slow progression”.[4] Common NCDs include cardiovascular diseases, cancers, 
chronic respiratory diseases, arthritis, diabetes, depression and obesity. Four major risk factors 
are often identified as the primary contributors to the growing prevalence of chronic diseases: 
tobacco use, unhealthy diets, physical inactivity and the harmful use of alcohol. However, 
many of these diseases and their associated risk factors are fundamentally, socially driven.[5] 
In Europe, a range of NCDS has been found to follow a social pattern whereby 
socioeconomic status (SES) predicts either a higher or lower risk of disease. To date however, 
comprehensive evidence on the social economic distribution of NCDs across Europe has been 
limited.   
Several studies have examined socioeconomic inequalities in the incidence and 
prevalence of specific NCDs in Europe. Evidence from longitudinal studies suggests that 
Europeans with lower SES have a higher incidence of cardiovascular problems, such as heart 
attack and stroke [6]. Other work indicates that cardiovascular disease mortality, diseases of 
the nervous system, obesity, diabetes, and arthritis are more common among lower 
socioeconomic groups.[7–11] Cancer, kidney diseases and skin diseases by contrast, have 
shown no association with SES, while allergy and back pain have been found to be more 
common among those with higher SES [8]. In terms of depression, some studies find an 
association with low SES[12], while others do not. [13] 
While providing important evidence on the social distribution of NCDs, a main 
limitation of many of these studies is their reliance on national-level survey data which differ 
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for example, in their sampling frames and questions on disease. Another limitation is that 
studies often examine inequalities by comparing the health of individuals at the very bottom 
of the SES hierarchy with those at the very top. This perspective ignores evidence that the 
association between SES and health follows a social gradient (i.e. that the association between 
SES and health exists at every level of the SES hierarchy). Examining social gradients in 
health is important because factors associated with very low SES may not account for 
differences in health status at higher levels.  
To date, Dalstra and colleagues provide the most comprehensive indication of 
European socioeconomic inequalities in NCDs.[8] This work however, relies on data from the 
1990s, is pooled from different national surveys, compares only a high and low SES group, 
and is limited to providing an overview of Western Europe. What is lacking is a more recent, 
comprehensive study of social gradients and socioeconomic inequalities in NCDs, both at a 
wider European and individual country-level. The objective of this study was to provide such 
an analysis.  
Methods 
This study was conducted as part of the NORFACE funded ‘HiNews’ project 
(https://www.dur.ac.uk/hinews/). It is based on cross-sectional data from the seventh round of 
the European Social Survey (ESS) and the rotating module ‘Social inequalities in health and 
their determinants’ described in detail by Eikemo and colleagues[14].  This module was fielded 
in 2014/15, comprising 37,623 respondents in 20 European countries: Austria, Belgium, 
Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Lithuania, 
Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Switzerland and the U.K.. 
Data was collected via face-to-face interviews with individuals aged 15 and over living in 
private households. The average response level for all countries was 51.6%, ranging from 
31.4% in Germany to 68.9% in Lithuania.  In line with previous studies using earlier ESS 
rounds, we included only respondents aged 25-75 in this study. We restricted our analyses to 
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this target population since inclusion of all ages would have yielded selectivity problems: 
people younger than 25 have often not yet completed their education and people over the age 
of 75 represent a very selective group of relatively healthy individuals[15]. After excluding 
individuals with missing data on study variables, a total of 25,011 respondents were used for 
our pooled analysis. Estonia and the Czech Republic are not included in the pooled analysis 
due to missing data on NCDs. These countries are however, included in the individual country 
analyses for the conditions where information was available. 
NCDs 
Data were analysed for 14 self-reported NCDs: heart/circulatory problems, high blood 
pressure, back pain, arm/hand pain, foot/leg pain, allergies, breathing problems, 
stomach/digestion problems, skin conditions, diabetes, severe headaches, cancer, obesity and 
depression. Data was collected on the first 11 of these conditions by providing participants 
with a list of conditions and asking them to indicate which they had experienced in the 
previous 12 months. Data on cancer was collected by asking respondents whether they have 
or have ever had cancer affecting any part of the body. For obesity, self-reported height and 
weight were converted to BMI.  Obesity was categorized as a BMI greater than 30. A 
depression scale was created by using an eight-item version of the Center for Epidemiological 
Studies Depression Scale (CES-D scale)[16]. This scale has been shown to be valid for cross-
national research.[17] For this paper we used a dichotomized measure of depression, as 
outlined in Huijts et al.[18]   
Socioeconomic status 
Education was used as the indicator of SES. Seven categories are used by the ESS to 
measure respondents’ highest educational level, reflecting the International Standard 
Classification of Education (ISCED). A low (ISCED I and II), medium (ISCED II, III and IV) 
and high (ISCED V) education group were constructed from these categories. This 
categorization was used because the proportion of respondents with less than secondary 
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education (i.e. ISCED I) is very low, and ISCED I may not fully capture, on its own, the 
lowest educated groups in these countries. 
Analyses 
For both a pooled European analysis and country-specific analyses, age-controlled 
adjusted risk ratios (ARR) were calculated from predicted probabilities generated by means of 
binary logistic regression.[19] These analyses separately compared the lower education group 
with the higher education group and the medium education group with the higher education 
group. We chose to calculate ARRs rather than odds ratios, as the latter are likely to be 
artificially high for non-rare conditions.[20] Moreover, ARRs are calculated from predicted 
probabilities, which are a preferred estimation method for cross-national comparisons of 
health inequalities. [21] This is because they do not rely on the assumption that error variance 
across countries is the same. Data were weighted using post-stratification population weights 
for the pooled analysis and design weights for the country specific analysis. These weights are 
reported in the ESS to correct for different population sizes between countries and use 
information on age-group, gender, education, and region to reduce the sampling error and 
potential non-response bias of the survey. In the pooled analysis, we accounted for the nesting 
of individuals within countries by estimating clustered standard errors. Country specific 
prevalences are presented as a supplementary file.  STATA 14.1 was used for all analyses. 
A social gradient in health was observed when significant differences were observed 
between both lower education groups and the high education group. When a difference was 
observed between only one of the lower education groups (i.e. either the lower or medium 
education group) and the high education group, we deemed this a socioeconomic gap.  
Results 
Table 1 summarizes the pooled ARRs for the different conditions. When examining 
men and women together, a social gradient in health was observed for ten NCDs in Europe: 
heart circulation problems, high blood pressure, breathing problems, hand/arm pain, foot/leg 
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pain, severe headaches, diabetes, obesity, depression and cancer. However, the CIs for the 
medium and low education groups overlapped for all of these conditions, with the exception 
of depression. An inverse social gradient (with a step-wise higher prevalence among the 
medium and high education group) was demonstrated for allergy, although here too the CIs 
for the medium and low education group overlapped. The largest socioeconomic gaps were 
observed for diabetes, obesity and depression. The ARRs for these conditions among both the 
medium and low education group were respectively, 1.79 (CI 1.47-2.19) and 2.36 (CI 2.05-
2.71) for diabetes, 1.49 (CI 1.29-1.72) and 1.93(CI 1.54-2.41) for obesity, and 1.91 (CI 1.61-
2.27) and 3.12 (CI 2.42-4.03) for depression.  
Social gradients were observed among both men and women for heart/circulation 
problems, high blood pressure, hand/arm pain, diabetes, obesity and depression. Additional 
social gradients were observed among women for breathing problems, foot/leg pain, severe 
headaches and cancer. An inverse social gradient was demonstrated among men for allergy 
but not among women. The CIs of the medium and low education group overlapped for all of 
these conditions except for hand/arm pain, diabetes and depression among women. Additional 
socioeconomic gaps were observed among men in the medium education group for severe 
headaches, as well as within the low education group for breathing problems. Lower risk was 
found among women in the medium education group for stomach/digestion problems and 
among women in the low education group for allergy and skin problems. Lower risk was 
found among men in the low education group for skin problems.  
The size of the socioeconomic gap in NCDs differed among the genders in different 
ways for different diseases. However, the CIs for men and women overlapped for all of the 
conditions with the exception of high blood pressure among the low education group. Here 
the ARR was notably larger among women with an ARR of 2.17 (CI 1.80-2.61) compared 
with an ARR of 1.22 (CI 1.01-1.48) among men.  
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Tables 2 and 3 provide a summary of observed social gradients and health gaps among 
women and men across individual countries (organized by region). Precise figures can be 
found in supplementary file 2. Patterns of social gradients and socioeconomic gaps differed 
across countries by both gender and disease, as well as by region. Across both women and 
men, the largest inequalities were generally found for heart/circulation problems, high blood 
pressure, hand/arm pain, diabetes, obesity and depression.  
A social gradient was observed among women in most countries for one to three 
diseases (see tables 2 and 3 for specific diseases), in addition to socioeconomic gaps which 
were found across all countries. The diseases with the greatest number of countries displaying 
social gradients or gaps among women were high blood pressure, hand/arm pain, obesity and 
depression. No social gradients were observed among women in the U.K.. By contrast, social 
gradients were observed for six NCDS in Lithuania.  
Overall, fewer social gradients and gaps were observed among men across individual 
countries. A social gradient was observed among men in many of the countries for 1 to 2 
diseases, in additional to socioeconomic gaps which were found across all countries (see 
tables 2 and 3 for specific diseases). The diseases with the greatest number of countries 
displaying social gradients or gaps among men were high blood pressure, hand/arm pain, 
obesity and depression. No social gradients were observed among men in Norway, Ireland, 
Poland, Slovenia, Hungary, Spain and Portugal. The greatest number of social gradients was 
observed among men in the U.K. (for three NCDs).  
With regard to regions, a few patterns were discernable although these differed across 
the genders. Among women, inequalities in heart/circulation problems were especially 
observed in Central/Eastern countries. Among men however, heart/circulation problems were 
observed in at least one country in every region except for the Southern. Additionally, no 
inequalities in diabetes were observed among women in Central/Eastern nor Southern 
countries. Among men, inequalities in diabetes were only observed in Western countries, with 
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the exception of the Czech Republic where lower risk was found for diabetes in the medium 
education group.  
Discussion 
Our analysis indicates that social gradients and socioeconomic gaps in the prevalence 
of NCDs are evident across the European population. However, the diseases with substantial 
inequalities across the education groups are different for men and women and individual 
countries.  
Previous research has reported varying patterns of socioeconomic inequalities for 
different NCDs. Similar to other studies, in our pooled analysis we observed among the lower 
education groups a higher risk for heart/circulation problems[8,22], high blood pressure[23], 
breathing-related problems[24], joint pain[22], headaches[8,22], diabetes [8,22,25–27], obesity[11] and 
depression[12]. As in our study, other work has also found higher risks of allergy among the 
more highly educated.[8]  
Some of our results differed from previous research. We found lower risk for 
back/neck pain among the low educated group, whereas others have found the risk of back 
pain greater among the lower educated.[22,28]  While some studies on migraine/headache, like 
us, have found greater prevalence among those with lower socioeconomic status[8,22], others 
have observed no difference.[29,30] In line with some previous research[31], we found a greater 
risk of skin problems among those of higher SES, although others have found no 
difference.[8,22] We found lower risk of stomach/digestion problems among the medium 
education group (and no difference in risk among the low education group), while others have 
reported greater risk among the lower education group.[25,32,33] Finally, previous studies have 
found conflicting socioeconomic inequalities for asthma and mental disorders, while we 
found breathing problems and depression to be more prevalent among the lower education 
groups.[8,13,34–38]  
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Some of the variation in reported inequalities almost certainly relates to the different 
criteria used to define the NCDs and measure SES. While our results are limited in that they 
cannot be directly compared with those of previous studies, the persistent finding of 
socioeconomic inequalities in NCDs remains a significant concern. Another limitation of this 
work is that it relies on self-reported data, rather than clinical diagnosis. However, while self-
reports may depend on characteristics of respondents other than the clinical presence of a 
condition, substantial accuracy has been found between physician reported medical histories 
and self-reports for many conditions.[8] Finally, although the ESS maintains a high standard of 
data collection, the survey is still prone to differences in response rates and cross-cultural 
quality of questions. For a further discussion on the strengths and weaknesses of the ESS data, 
see Eikemo et al..[14] 
Our results raise questions about the factors which might explain the differences in 
social gradients and inequalities in NCDs, as well as the differences found between the 
genders and individual countries. We would expect that these factors relate to a range of 
policy differences that shape living and working conditions in different countries. Future work 
should perform more in-depth analyses towards explaining these differences. 
Our country-level analyses show that inequalities in NCDs are present everywhere 
across Europe and that health inequalities exist (to different extents) for each of the 14 
investigated NCDs. At the European regional level, inequalities in both heart/circulation 
problems and diabetes seem to follow different patterns across the genders. Moreover, we 
observed no inequalities in these conditions in Southern countries, despite significant 
inequalities in other regions. Previous research has also found smaller inequalities in heart 
disease in Southern countries.[8] 
This study provides the most up-to-date overview of the social gradients and 
socioeconomic gaps for a large number of NCDs across 20 European countries for both men 
and women. It is the first study to do so in a way in which reliable comparisons between 
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countries can be made. We identified large variations between NCDs with regard to both 
social gradients and socioeconomic gaps. Future work seeking to explain health inequalities 
should further consider the diseases, and their associated determinants, for which 
socioeconomic differences are the greatest.  
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Table 1 Adjusted rate ratios and 95% CIs (medium vs high education and low vs high education) for NCDs in Europe.  
Chronic Disease Educ. 
Women & Men  
(25-75) 
Women (25-75) Men (25-75) 
Heart/Circulation Med 1.55 1.19 2.02 1.54 1.23 1.93 1.60 1.07 2.39 
(n=2,382) Low 1.67 1.37 2.03 1.69 1.38 2.06 1.69 1.29 2.20 
High Blood Pressure Med 1.50 1.38 1.63 1.75 1.45 2.11 1.35 1.22 1.49 
(n=4,666) Low 1.61 1.48 1.77 2.17 1.80 2.61 1.22 1.01 1.48 
Breathing Problem Med 1.19 1.02 1.39 1.22 1.08 1.37 1.18 0.93 1.49 
(n=2,044) Low 1.50 1.28 1.78 1.69 1.35 2.13 1.32 1.15 1.52 
Allergies Med 0.83 0.76 0.92 0.90 0.79 1.03 0.76 0.65 0.89 
 (n=3,050) Low 0.68 0.60 0.78 0.78 0.64 0.94 0.54 0.44 0.65 
Skin Med 0.89 0.71 1.11 0.87 0.76 1.00 0.92 0.64 1.32 
(n=2,176) Low 0.60 0.47 0.76 0.66 0.55 0.79 0.51 0.37 0.70 
Back or Neck Pain Med 1.14 0.99 1.30 1.13 1.00 1.27 1.15 0.98 1.34 
 (n=10,307) Low 0.99 0.85 1.14 0.95 0.84 1.07 1.02 0.85 1.24 
Hand or Arm Pain Med 1.33 1.14 1.56 1.24 1.10 1.40 1.44 1.16 1.78 
(n=5,637) Low 1.64 1.47 1.84 1.67 1.52 1.84 1.56 1.28 1.90 
Foot or Leg Pain Med 1.11 1.00 1.23 1.08 0.98 1.19 1.12 0.98 1.28 
 (n=5,969) Low 1.23 1.11 1.36 1.30 1.18 1.42 1.12 0.94 1.34 
Severe Headaches Med 1.25 1.03 1.51 1.25 1.05 1.49 1.31 1.04 1.64 
(n=3,415) Low 1.28 1.01 1.63 1.32 1.05 1.66 1.15 0.89 1.48 
Stomach/digestion Med 0.88 0.81 0.95 0.82 0.78 0.85 0.97 0.83 1.13 
 (n=4,055) Low 0.91 0.73 1.14 0.91 0.75 1.10 0.88 0.67 1.16 
Diabetes Med 1.79 1.47 2.19 1.37 1.17 1.61 2.22 1.58 3.14 
(n=1,332) Low 2.36 2.05 2.71 2.36 1.79 3.10 2.38 1.52 3.73 
Obesity Med 1.49 1.28 1.72 1.57 1.19 2.08 1.42 1.32 1.52 
 (n=4,148) Low 1.93 1.54 2.41 2.33 1.63 3.32 1.62 1.28 2.04 
Depression Med 1.91 1.61 2.27 1.86 1.61 2.15 2.06 1.50 2.82 
(n=3,029) Low 3.12 2.42 4.03 3.16 2.49 4.02 2.88 2.19 3.79 
Cancer Med 1.20 1.07 1.35 1.17 1.04 1.32 1.26 1.00 1.58 
 (n=2,691) Low 1.23 1.11 1.38 1.24 1.02 1.51 1.19 0.99 1.43 
Bold indicates CI does not contain 1.00. Models adjusted for age.  
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Table 2. Summary Table of Social Gradients and Socioeconomic Gaps Among Women 
 
 
Heart HBP Breathing Allergies Skin Back/Neck Hand/Arm Foot/leg Headaches Stomach Diabetes Obesity Depression Cancer 
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  X L 
 
M  L L X 
 Finland (n=797) 
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X L L 
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 Portugal (n=505) 
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L X 
 Spain (n=686) 
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  L(I) L(I) 
 
  
 
L(I)  
 
L X 
 X= Social gradient; (I)=Inverse gradient; M=Socioeconomic gap between the medium and high education group; L=Socioeconomic gap between the low and high education 
group. Shading indicates data was not available.  
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Table 3. Summary Table of Social Gradients and Socioeconomic Gaps Among Men 
 
Heart HBP Breathing Allergies Skin Back/Neck Hand/Arm Foot/leg Headaches Stomach Diabetes Obesity Depression Cancer 
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 X= Social Gradient (I)=Inverse Gradient M=Socioeconomic Gap between the medium and high education group L=Socioeconomic Gap between the low and high education group. 
Shading indicates data was not available. 
 
